Dr. Weizhou Zhang and other researchers produce first-of-its-kind drug to effectively kill aggressive acute myeloid leukemia cells. Published On September 30, 2026 Social Media Share this article Facebook Twitter LinkedIn Breakthroughs begin here: Developing a duo-targeting cancer drug
